In this study, a series of conformationally restricted thieno[3,2-d]pyrimidinones, thieno[3,2-d]pyrimidines and quinazolinones was designed and synthesized with the goal of improving the biological activity as 17-hydroxysteroid dehydrogenase type 2 inhibitors of the corresponding amidothiophene derivatives. Two moderately active compounds were discovered and this allowed the identification of the biologically active open conformer as well as the extension of the enzyme binding site characterisation
Enzymes such as aromatase, 17[beta]-hydroxysteroid dehydrogenase [types 1 (17[beta]-HSD1) and 3 (17[...
ABSTRACT: 17β-Hydroxysteroid dehydrogenase 2 (17β-HSD2) catalyzes the inactivation of estradiol into...
17β-estradiol (E2), the most potent estrogen in humans, known to be involved in the development and ...
In this study, a series of conformationally restricted thieno[3,2-d]pyrimidinones, thieno[3,2-d]pyri...
In this study, a series of conformationally restricted thieno[3,2-d]pyrimidinones, thieno[3,2-d]pyri...
Inhibition of 17β-HSD2 is an attractive mechanism for the treatment of osteoporosis. We report ...
Inhibition of 17β-HSD2 is an attractive mechanism for the treatment of osteoporosis. We report here ...
17β-HSD2 is a new promising target for the treatment of osteoporosis. In the first part of this thes...
Estradiol is the most potent estrogen in humans. It is known to be involved in the development and p...
17β-HSD2 is a promising new target for the treatment of osteoporosis. In this paper, a rational stra...
Using a ligand-based approach, we designed and synthesised novel non-steroidal 17beta-HSD2 inhibitor...
<div><p>17β-estradiol (E2), the most potent estrogen in humans, known to be involved in the developm...
Design and synthesis of a new class of inhibitors for the treatment of osteoporosis and its comparat...
17β-Hydroxysteroid dehydrogenase type 2 (17β-HSD2) converts the potent estrogen estradiol into the w...
This paper describes the synthesis of 1,4-dihydropyridine compounds (DHPs) endowed with good muscle ...
Enzymes such as aromatase, 17[beta]-hydroxysteroid dehydrogenase [types 1 (17[beta]-HSD1) and 3 (17[...
ABSTRACT: 17β-Hydroxysteroid dehydrogenase 2 (17β-HSD2) catalyzes the inactivation of estradiol into...
17β-estradiol (E2), the most potent estrogen in humans, known to be involved in the development and ...
In this study, a series of conformationally restricted thieno[3,2-d]pyrimidinones, thieno[3,2-d]pyri...
In this study, a series of conformationally restricted thieno[3,2-d]pyrimidinones, thieno[3,2-d]pyri...
Inhibition of 17β-HSD2 is an attractive mechanism for the treatment of osteoporosis. We report ...
Inhibition of 17β-HSD2 is an attractive mechanism for the treatment of osteoporosis. We report here ...
17β-HSD2 is a new promising target for the treatment of osteoporosis. In the first part of this thes...
Estradiol is the most potent estrogen in humans. It is known to be involved in the development and p...
17β-HSD2 is a promising new target for the treatment of osteoporosis. In this paper, a rational stra...
Using a ligand-based approach, we designed and synthesised novel non-steroidal 17beta-HSD2 inhibitor...
<div><p>17β-estradiol (E2), the most potent estrogen in humans, known to be involved in the developm...
Design and synthesis of a new class of inhibitors for the treatment of osteoporosis and its comparat...
17β-Hydroxysteroid dehydrogenase type 2 (17β-HSD2) converts the potent estrogen estradiol into the w...
This paper describes the synthesis of 1,4-dihydropyridine compounds (DHPs) endowed with good muscle ...
Enzymes such as aromatase, 17[beta]-hydroxysteroid dehydrogenase [types 1 (17[beta]-HSD1) and 3 (17[...
ABSTRACT: 17β-Hydroxysteroid dehydrogenase 2 (17β-HSD2) catalyzes the inactivation of estradiol into...
17β-estradiol (E2), the most potent estrogen in humans, known to be involved in the development and ...